1. Home
  2. ARCT vs JACS Comparison

ARCT vs JACS Comparison

Compare ARCT & JACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • JACS
  • Stock Information
  • Founded
  • ARCT 2013
  • JACS 2024
  • Country
  • ARCT United States
  • JACS United States
  • Employees
  • ARCT N/A
  • JACS N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • JACS
  • Sector
  • ARCT Health Care
  • JACS
  • Exchange
  • ARCT Nasdaq
  • JACS NYSE
  • Market Cap
  • ARCT 298.3M
  • JACS 298.3M
  • IPO Year
  • ARCT N/A
  • JACS 2024
  • Fundamental
  • Price
  • ARCT $11.86
  • JACS $10.21
  • Analyst Decision
  • ARCT Strong Buy
  • JACS
  • Analyst Count
  • ARCT 7
  • JACS 0
  • Target Price
  • ARCT $57.40
  • JACS N/A
  • AVG Volume (30 Days)
  • ARCT 410.5K
  • JACS 99.0K
  • Earning Date
  • ARCT 05-12-2025
  • JACS 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • JACS N/A
  • EPS Growth
  • ARCT N/A
  • JACS N/A
  • EPS
  • ARCT N/A
  • JACS N/A
  • Revenue
  • ARCT $143,680,000.00
  • JACS N/A
  • Revenue This Year
  • ARCT N/A
  • JACS N/A
  • Revenue Next Year
  • ARCT $44.93
  • JACS N/A
  • P/E Ratio
  • ARCT N/A
  • JACS $263.48
  • Revenue Growth
  • ARCT 15.38
  • JACS N/A
  • 52 Week Low
  • ARCT $8.04
  • JACS $9.94
  • 52 Week High
  • ARCT $45.00
  • JACS $10.41
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 50.74
  • JACS N/A
  • Support Level
  • ARCT $10.70
  • JACS N/A
  • Resistance Level
  • ARCT $13.10
  • JACS N/A
  • Average True Range (ATR)
  • ARCT 0.89
  • JACS 0.00
  • MACD
  • ARCT -0.01
  • JACS 0.00
  • Stochastic Oscillator
  • ARCT 35.69
  • JACS 0.00

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About JACS JACKSON ACQUISITION COMPANY II

Jackson Acquisition Co II is a newly incorporated blank check company.

Share on Social Networks: